STAT3 and colonic neoplasm: Here, our additional assays showed that JAK/STAT3 signaling inhibitor AG490 at 50 μM, unlike α-hederin, failed to repress the viability of SW620 cells (Figure 6(a)), suggesting that the JAK2/STAT3 signaling might specifically regulate the EMT of colon cancer cells.